Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Cross-linkable mitochondria-targeted PEGylated phospholipid medicinal material and its preparation method and application

A technology of PEGylated phospholipids and mitochondria, which is applied in the field of phospholipid medicinal materials and its preparation, can solve the problems of reducing tumor tissue targeting, poor long-term stability of DKD liposomes, unfavorable liposomes, etc., and achieves The effect of prolonging the circulation time in the body, good long-term circulation function, and good stability

Active Publication Date: 2017-10-31
SICHUAN UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, DKD still has the following deficiencies: 1) DKD does not have a long-term circulation function, resulting in the rapid clearance of DKD liposomes in blood vessels, which is not conducive to the delivery of anticancer drugs across the vascular barrier; 2) the drug-loaded liposomes prepared by DKD Nano-liposomes are nano-aggregates formed by the assembly of molecules through non-covalent bonds. They are unstable in the blood circulation and transmembrane process, and are easy to disintegrate, resulting in the early release of drugs before reaching the target and failing to achieve therapeutic effects. And after the medicine goes off the target and enters the normal tissue, it is very easy to cause serious toxic and side effects; 3) because the molecular structure of DKD does not have a hydrophilic protective layer, the prepared DKD liposomes are prone to agglomeration after being placed for a period of time, and the particle size becomes larger. It is not conducive to the entry of liposomes from blood vessels into tissues, thereby reducing the targeting of tumor tissues, and there are safety hazards such as blocking capillaries
Therefore, the long-term stability of DKD liposomes is not good, which is not conducive to long-term storage

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cross-linkable mitochondria-targeted PEGylated phospholipid medicinal material and its preparation method and application
  • Cross-linkable mitochondria-targeted PEGylated phospholipid medicinal material and its preparation method and application
  • Cross-linkable mitochondria-targeted PEGylated phospholipid medicinal material and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] The cross-linkable mitochondria-targeted pegylated distearoylphosphatidylethanolamine (DSPE-PEG2000-KLA) described in this example has a structural formula:

[0036]

[0037] The preparation method is as follows:

[0038] Distearoylphosphatidylethanolamine-polyethylene glycol 2000-maleimide (DSPE-PEG2000-Mal), polypeptide D-(KLAKLAK) 2 -C 5 And triethylamine as raw material, polypeptide D-(KLAKLAK) 2 -C 5 , triethylamine, the mol ratio of DSPE-PEG2000-Mal is 1:1:1;

[0039] Under nitrogen protection, DSPE-PEG2000-Mal, triethylamine and chloroform were mixed uniformly to obtain the first solution, and the amount of chloroform was such that the concentration of DSPE-PEG2000-Mal in the first solution was 100mmol / L, triethylamine The concentration is 100mmol / L;

[0040] Under nitrogen protection, the polypeptide D-(KLAKLAK) 2 -C 5 Dissolved in methanol to obtain the second solution, the amount of methanol is to make the polypeptide D-(KLAKLAK) in the second soluti...

Embodiment 2

[0043] The cross-linkable mitochondria-targeted PEGylated dimyristoylphosphatidylethanolamine (DMPE-PEG2000-KLA) described in this example has a structural formula:

[0044]

[0045] The preparation method is as follows:

[0046] Dimyristoylphosphatidylethanolamine-polyethylene glycol 2000-maleimide (DMPE-PEG2000-Mal), polypeptide D-(KLAKLAK) 2 -C 5 And 4-dimethylaminopyridine as raw material, polypeptide D-(KLAKLAK) 2 -C 5 , 4-dimethylaminopyridine, the mol ratio of DMPE-PEG2000-Mal is 2:2:1;

[0047] Under nitrogen protection, mix DMPE-PEG2000-Mal, 4-dimethylaminopyridine, and dichloromethane evenly to obtain the first solution. The amount of dichloromethane is such that the concentration of DMPE-PEG2000-Mal in the first solution is 200mmol / L, the concentration of 4-dimethylaminopyridine is 400mmol / L;

[0048] Under nitrogen protection, the polypeptide D-(KLAKLAK) 2 -C 5 Be dissolved in N, in the N-dimethylformamide, obtain the second solution, the consumption of ...

Embodiment 3

[0051] The cross-linkable mitochondria-targeted PEGylated dipalmitoylphosphatidylethanolamine (DPPE-PEG2000-KLA) described in this example has a structural formula:

[0052]

[0053] The preparation method is as follows:

[0054] Dipalmitoylphosphatidylethanolamine-polyethylene glycol 2000-maleimide (DPPE-PEG2000-Mal), polypeptide D-(KLAKLAK) 2 -C 5 And N, N-diisopropylethylamine as raw material, polypeptide D-(KLAKLAK) 2 -C 5 , N, the molar ratio of N-diisopropylethylamine, DPPE-PEG2000-Mal is 3:3:1;

[0055] Under the protection of nitrogen, mix DPPE-PEG2000-Mal, N,N-diisopropylethylamine, and dichloromethane evenly to obtain the first solution. The amount of dichloromethane in the first solution is to make DPPE-PEG2000- The concentration of Mal is 300mmol / L, and the concentration of N,N-diisopropylethylamine is 900mmol / L;

[0056] Under nitrogen protection, the polypeptide D-(KLAKLAK) 2 -C 5 Be dissolved in N, in the N-dimethylformamide, obtain the second solution...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The cross-linkable mitochondria-targeting pegylated phospholipid pharmaceutical material of the present invention has the following structural formula: n=10, 12, 14, 16. Preparation method: using fatty acid acylphosphatidylethanolamine-polyethylene glycol-maleimide, polypeptide D-(KLAKLAK)2-C5 and organic base as raw materials, polypeptide, organic base, fatty acid acylphosphatidylethanolamine-polyethylene glycol The mol ratio of alcohol-maleimide is (1~3):(1~3):1; under nitrogen protection, fatty acid acylphosphatidylethanolamine-polyethylene glycol-maleimide, organic base Mixing with the first solvent to obtain a first solution, dissolving the polypeptide in a second solvent to obtain a second solution, mixing the first solution and the second solution, and stirring and reacting for 12 to 48 hours at 20 to 40° C. in the dark. The drug-loaded liposome prepared by using the medicinal material can further improve the tumor treatment effect, reduce toxic and side effects and facilitate long-term storage.

Description

technical field [0001] The invention belongs to the technical field of medicine and its preparation, and in particular relates to a phospholipid medicinal material and its preparation method and application. Background technique [0002] Chemotherapy is one of the main ways to treat cancer, but the mortality rate of cancer patients after chemotherapy is still high. Multidrug resistance (MDR) is one of the main reasons for clinical chemotherapy failure. The drug resistance of tumor cells can be divided into two categories: congenital and acquired. Studies have shown that changes in tumor cell genes or gene phenotypes lead to changes in apoptosis pathways, which eventually lead to the emergence of tumor innate drug resistance. Mitochondria are the "power factory" of the cell and also the "suicide arsenal", which can initiate the apoptosis pathway. Therefore, the innate drug resistance of tumor cells is closely related to the abnormal function of mitochondria. Taking mitocho...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K47/42A61K9/127A61P35/00C08G65/00A61K31/337
Inventor 李莉顾忠伟姜雷孙家维
Owner SICHUAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products